Janet McLaughlin


Janet McLaughlin is an Associate Professor of Health Studies and a Research Associate with the International Migration Research Centre at Wilfrid Laurier University. She is an interdisciplinary scholar trained in medical anthropology, with interests in the areas of global and environmental health, food systems, labour, social justice, citizenship, transnational migration and the social impacts of autism. Her research and publications have focused on various areas of migrant workers’ health, rights and well-being, including: access to health care and workers’ compensation; women’s experiences of gender-based violence; occupational, mental, sexual and reproductive health; social determinants of health; and the impacts of separation on migrant families. She is co-founder of the Migrant Worker Health Project, www.migrantworkerhealth.ca, which promotes accessible health care for migrant workers. Dr. McLaughlin is currently researching autism policy and family impacts in Ontario.

From this contributor

Explore more from The Transmitter

Grid of human brain scans.

Dose, scan, repeat: Tracking the neurological effects of oral contraceptives

We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.

By Carina Heller
20 January 2025 | 7 min read
Colorful illustration of a latticework of proteins.

Cracking the code of the extracellular matrix

Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.

By Anna Victoria Molofsky
17 January 2025 | 5 min read
A repeated DNA strand extends farther from the left side of the image with each iteration.

Huntington’s disease gene variants past a certain size poison select cells

The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.

By Angie Voyles Askham
16 January 2025 | 6 min read